Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, Birkenfeld S, Leshno M, Niv Y
Gastroenterology Department, Rabin Medical Center, Beilinson Hospital, Petach Tikva.
Aliment Pharmacol Ther. 2009 Apr 15;29(8):906-17. doi: 10.1111/j.1365-2036.2009.03946.x.
Faecal occult blood tests (FOBT) are faulted by low sensitivity for advanced adenomatous polyps (AAP). Quantified, immunochemical, haemoglobin (Hb)-specific immunochemical FOBT (I-FOBT) measurements are now used for colorectal screening.
To correlate adenoma characteristics to amount of faecal Hb lost and to evaluate sensitivity and specificity for AAP by faecal Hb development threshold used and number of I-FOBTs collected.
Three daily I-FOBTs were collected and analysed in 1221 patients scheduled for colonoscopy. Faecal Hb was analysed as ngHb/mL of buffer and the highest result related to colonoscopy findings.
In 1204 patients without cancer, colonoscopy identified adenomas in 294, 99 with AAPs. Adenoma patients had elevated faecal Hb increasing with advanced histology, size, pedunculated shape and multiplicity (P < 0.001 for all). At 50 ngHb/mL threshold, sensitivity and specificity for AAPs were 54.5% (95%CI 44.7, 64.7) and 88.1% (95%CI 86.2, 90.1) for three tests. At higher thresholds, sensitivity decreased, but was significantly higher with more samples collected. Conversely, specificity increased at higher thresholds, but decreased with more samples.
Faecal Hb loss from adenomas is significantly associated with size, number and advanced features. Sensitivity and specificity for AAPs are determined by test threshold chosen and number of samples collected; these determine the number of colonoscopies needed for positive tests.
粪便潜血试验(FOBT)对进展期腺瘤性息肉(AAP)的敏感性较低。目前,定量、免疫化学、血红蛋白(Hb)特异性免疫化学粪便潜血试验(I-FOBT)测量用于结直肠癌筛查。
将腺瘤特征与粪便Hb丢失量相关联,并通过所使用的粪便Hb发展阈值和收集的I-FOBT数量评估AAP的敏感性和特异性。
对1221例计划进行结肠镜检查的患者收集并分析连续三天的I-FOBT。粪便Hb分析为每毫升缓冲液中的纳克Hb(ngHb/mL),最高结果与结肠镜检查结果相关。
在1204例无癌症患者中,结肠镜检查发现294例有腺瘤,其中99例有AAP。腺瘤患者的粪便Hb升高,随着组织学进展、大小、有蒂形状和多发性增加(所有P<0.001)。在50 ngHb/mL阈值下,三次检测对AAP的敏感性和特异性分别为54.5%(95%CI 44.7, 64.7)和88.1%(95%CI 86.2, 90.1)。在更高的阈值下,敏感性降低,但收集更多样本时显著更高。相反,特异性在更高阈值时增加,但随着样本增多而降低。
腺瘤导致的粪便Hb丢失与大小、数量和进展特征显著相关。AAP的敏感性和特异性由所选的检测阈值和收集的样本数量决定;这些决定了阳性检测所需的结肠镜检查数量。